YBGJ Stock Overview
Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Yubo International Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.50 |
| 52 Week High | US$1.04 |
| 52 Week Low | US$0.065 |
| Beta | -0.14 |
| 1 Month Change | -49.61% |
| 3 Month Change | n/a |
| 1 Year Change | 474.11% |
| 3 Year Change | -50.11% |
| 5 Year Change | n/a |
| Change since IPO | -84.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| YBGJ | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -47.5% | 2.7% | 0.3% |
| 1Y | 474.1% | 2.9% | 24.2% |
Return vs Industry: YBGJ exceeded the US Biotechs industry which returned 1.2% over the past year.
Return vs Market: YBGJ exceeded the US Market which returned 22.8% over the past year.
Price Volatility
| YBGJ volatility | |
|---|---|
| YBGJ Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: YBGJ's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine YBGJ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 18 | Yang Wang | www.yubogroup.com |
Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.
Yubo International Biotech Limited Fundamentals Summary
| YBGJ fundamental statistics | |
|---|---|
| Market cap | US$53.92m |
| Earnings (TTM) | -US$1.20m |
| Revenue (TTM) | US$604.68k |
98.9x
P/S Ratio-50.0x
P/E RatioIs YBGJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YBGJ income statement (TTM) | |
|---|---|
| Revenue | US$604.68k |
| Cost of Revenue | US$185.49k |
| Gross Profit | US$419.19k |
| Other Expenses | US$1.61m |
| Earnings | -US$1.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | 69.32% |
| Net Profit Margin | -197.64% |
| Debt/Equity Ratio | 0% |
How did YBGJ perform over the long term?
See historical performance and comparison